IBDEI1L6 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,28506,1,2,0)
 ;;=2^242.90
 ;;^UTILITY(U,$J,358.3,28506,1,5,0)
 ;;=5^HYPERTHYROIDISM
 ;;^UTILITY(U,$J,358.3,28506,2)
 ;;=^267811
 ;;^UTILITY(U,$J,358.3,28507,0)
 ;;=272.1^^176^1812^33
 ;;^UTILITY(U,$J,358.3,28507,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28507,1,2,0)
 ;;=2^272.1
 ;;^UTILITY(U,$J,358.3,28507,1,5,0)
 ;;=5^HYPERTRIGLYCERIDEMIA
 ;;^UTILITY(U,$J,358.3,28507,2)
 ;;=^101303
 ;;^UTILITY(U,$J,358.3,28508,0)
 ;;=251.2^^176^1812^34
 ;;^UTILITY(U,$J,358.3,28508,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28508,1,2,0)
 ;;=2^251.2
 ;;^UTILITY(U,$J,358.3,28508,1,5,0)
 ;;=5^HYPOGLYCEMIA NOS
 ;;^UTILITY(U,$J,358.3,28508,2)
 ;;=^60580
 ;;^UTILITY(U,$J,358.3,28509,0)
 ;;=276.1^^176^1812^35
 ;;^UTILITY(U,$J,358.3,28509,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28509,1,2,0)
 ;;=2^276.1
 ;;^UTILITY(U,$J,358.3,28509,1,5,0)
 ;;=5^HYPONATREMIA
 ;;^UTILITY(U,$J,358.3,28509,2)
 ;;=^60722
 ;;^UTILITY(U,$J,358.3,28510,0)
 ;;=276.8^^176^1812^36
 ;;^UTILITY(U,$J,358.3,28510,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28510,1,2,0)
 ;;=2^276.8
 ;;^UTILITY(U,$J,358.3,28510,1,5,0)
 ;;=5^HYPOPOTASSEMIA
 ;;^UTILITY(U,$J,358.3,28510,2)
 ;;=^60611
 ;;^UTILITY(U,$J,358.3,28511,0)
 ;;=458.9^^176^1812^37
 ;;^UTILITY(U,$J,358.3,28511,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28511,1,2,0)
 ;;=2^458.9
 ;;^UTILITY(U,$J,358.3,28511,1,5,0)
 ;;=5^HYPOTENSION NOS
 ;;^UTILITY(U,$J,358.3,28511,2)
 ;;=^60729
 ;;^UTILITY(U,$J,358.3,28512,0)
 ;;=244.9^^176^1812^38
 ;;^UTILITY(U,$J,358.3,28512,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28512,1,2,0)
 ;;=2^244.9
 ;;^UTILITY(U,$J,358.3,28512,1,5,0)
 ;;=5^HYPOTHYROIDISM NOS
 ;;^UTILITY(U,$J,358.3,28512,2)
 ;;=^123752
 ;;^UTILITY(U,$J,358.3,28513,0)
 ;;=380.4^^176^1813^1
 ;;^UTILITY(U,$J,358.3,28513,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28513,1,2,0)
 ;;=2^380.4
 ;;^UTILITY(U,$J,358.3,28513,1,5,0)
 ;;=5^IMPACTED CERUMEN
 ;;^UTILITY(U,$J,358.3,28513,2)
 ;;=^62061
 ;;^UTILITY(U,$J,358.3,28514,0)
 ;;=607.84^^176^1813^2
 ;;^UTILITY(U,$J,358.3,28514,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28514,1,2,0)
 ;;=2^607.84
 ;;^UTILITY(U,$J,358.3,28514,1,5,0)
 ;;=5^IMPOTENCE
 ;;^UTILITY(U,$J,358.3,28514,2)
 ;;=^270441
 ;;^UTILITY(U,$J,358.3,28515,0)
 ;;=998.59^^176^1813^3
 ;;^UTILITY(U,$J,358.3,28515,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28515,1,2,0)
 ;;=2^998.59
 ;;^UTILITY(U,$J,358.3,28515,1,5,0)
 ;;=5^INFECTION,POST-OP
 ;;^UTILITY(U,$J,358.3,28515,2)
 ;;=^97081
 ;;^UTILITY(U,$J,358.3,28516,0)
 ;;=487.1^^176^1813^6
 ;;^UTILITY(U,$J,358.3,28516,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28516,1,2,0)
 ;;=2^487.1
 ;;^UTILITY(U,$J,358.3,28516,1,5,0)
 ;;=5^INFLUENZA
 ;;^UTILITY(U,$J,358.3,28516,2)
 ;;=^63125
 ;;^UTILITY(U,$J,358.3,28517,0)
 ;;=780.52^^176^1813^7
 ;;^UTILITY(U,$J,358.3,28517,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28517,1,2,0)
 ;;=2^780.52
 ;;^UTILITY(U,$J,358.3,28517,1,5,0)
 ;;=5^INSOMNIA NOS
 ;;^UTILITY(U,$J,358.3,28517,2)
 ;;=^332924
 ;;^UTILITY(U,$J,358.3,28518,0)
 ;;=564.1^^176^1813^8
 ;;^UTILITY(U,$J,358.3,28518,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28518,1,2,0)
 ;;=2^564.1
 ;;^UTILITY(U,$J,358.3,28518,1,5,0)
 ;;=5^IRRITABLE BOWEL SYNDROME
 ;;^UTILITY(U,$J,358.3,28518,2)
 ;;=^65682
 ;;^UTILITY(U,$J,358.3,28519,0)
 ;;=686.9^^176^1813^4
 ;;^UTILITY(U,$J,358.3,28519,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28519,1,2,0)
 ;;=2^686.9
 ;;^UTILITY(U,$J,358.3,28519,1,5,0)
 ;;=5^INFECTION,SKIN
 ;;^UTILITY(U,$J,358.3,28519,2)
 ;;=^123943
 ;;^UTILITY(U,$J,358.3,28520,0)
 ;;=782.4^^176^1814^1
 ;;^UTILITY(U,$J,358.3,28520,1,0)
 ;;=^358.31IA^5^2
